Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jinxin Fertility Group Buyback Yield % Related Terms
Jinxin Fertility Group Buyback Yield % Historical Data
* Premium members only.
The historical data trend for Jinxin Fertility Group's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:3NX vs HCA, THC, DVA: Buyback Yield % Comparison
For the Medical Care Facilities subindustry, Jinxin Fertility Group's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jinxin Fertility Group Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jinxin Fertility Group's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Jinxin Fertility Group's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jinxin Fertility Group (FRA:3NX) has a Buyback Yield % of 1.78 as of Aug. 11, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Jinxin Fertility Group and its competitors. According to the industry distribution chart, Jinxin Fertility Group ranks #59 out of 265 companies in the Healthcare Providers & Services industry, placing it in the top 22.3%.
Is Jinxin Fertility Group's Buyback Yield % too high?
Jinxin Fertility Group's current Buyback Yield % is 1.78. Based on the distribution chart, Jinxin Fertility Group ranks #59 out of 265 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Jinxin Fertility Group has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Jinxin Fertility Group's Buyback Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jinxin Fertility Group ranks #59 out of 265 companies for Buyback Yield %. This places Jinxin Fertility Group in the top 22% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Jinxin Fertility Group and its competitors. Jinxin Fertility Group's current Buyback Yield % is 1.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinxin Fertility Group stock overvalued right now?
Jinxin Fertility Group (FRA:3NX) has a current Buyback Yield % of 1.78. The stock's GF Value™ is €0.32, compared to a current price of €0.23 — trading 29.4% below its estimated fair value. The current Buyback Yield % is 1.78. Jinxin Fertility Group's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Jinxin Fertility Group (FRA:3NX), the current Buyback Yield % is 1.78 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jinxin Fertility Group (FRA:3NX) Overvalued in 2026?
Based on GuruFocus' analysis, Jinxin Fertility Group stock appears to be undervalued.
The current stock price of €0.23 is trading 29.4% below its estimated GF Value™ of €0.32.
Key valuation signals for FRA:3NX:
Buyback Yield %: 1.78
GF Value™: €0.32 vs. price of €0.23 (29.4% below fair value)
No single metric tells the full story. See the FRA:3NX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jinxin Fertility Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in providing IVF services in both China and the United States. The firm, through its subsidiary, is engaged in Assisted reproductive services, management services, ambulatory surgery centre facilities services, obstetrics, gynecology & pediatrics medical services, sales of medical consumables and equipment. and ancillary medical services. Geographically, the company generates a majority of its revenue from Greater China, with a small portion of revenue generated from Overseas Business.
81GF Score
Get the complete analysis for FRA:3NX
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3NX has been successfully added to your 
